We are developing the next generation of diagnostic and monitoring solutions for people with worsening heart failure.

The Next Generation of Swan-Ganz Catheter
Improving Treatment of Worsening Heart Failure​

HemoCath is the next generation of flow-directed pulmonary artery (Swan-Ganz) catheters. It provides the most important measures of fluid status in heart failure patients  —  ​pulmonary artery pressure (PA), central venous pressure (CVP) and cardiac output (CO)  —  simultaneously in real time  —  easily inserted in a vein in the upper arm.

HemoCath directly monitors PA, CVP and CO continuously over several hours or days  —   allowing more accurate medication dosing  —   ​improving patient outcomes  —   potentially reducing hospitalization and 30-day hospital readmission. 

Intelligent Hemodynamic Monitoring Platform
Proactive Care for People with Heart Failure​

Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide  —  ​5.7 million people in the US  —  and projections in the near future are worrisome. HF health expenditures are considerable and will increase dramatically with an ageing population.

HemoCloud is an intelligent hemodynamic monitoring platform that closely monitors a patient's heart and notifies healthcare professionals when a patient's condition is worsening.